
U.S. loses measles elimination status; neither shot nor surgery for most teens with severe obesity; Florida man pleads guilty in $42M Medicare fraud — Morning Medical Update
Key Takeaways
- PAHO’s elimination-status reversal reflects outbreaks persisting beyond 12 months, underscoring failures in interruption of transmission rather than “zero-case” expectations.
- Measles morbidity has escalated to >5,000 confirmed 2026 cases and 13 reported deaths, highlighting consequences of immunization gaps and contested federal/state response actions.
The top news stories in medicine today.
U.S. loses measles elimination status
Measles has spread inside the country for more than a year without a break.
The United States has
Elimination does not mean zero cases. It means outbreaks end within a year, and that is no longer happening in the U.S. PAHO relied on two analyses, one by the Centers for Disease Control and Prevention (CDC) and one by an independent group of measles experts. Researchers had expected the outcome after an outbreak in Utah passed the one-year mark in June.
The CDC has reported
A spokesperson for the U.S. Department of Health and Human Services (HHS) attributed the resurgence to vaccination gaps that predate the current administration and said HHS Secretary Robert F. Kennedy Jr. and the CDC have provided about $100 million in additional outbreak funding. Critics have pointed to cuts to state immunization grants, delayed or blocked CDC reports and Kennedy's statements on vaccines.
“It's a very sad moment,” said Anne Schuchat, M.D., a former CDC deputy director.
Neither shot nor surgery for most teens with severe obesity
GLP-1 prescriptions rose 35-fold, yet nine in 10 eligible adolescents got neither treatment.
Researchers at Ann & Robert H. Lurie Children's Hospital of Chicago
GLP-1 prescribing climbed from 301 per 100,000 eligible adolescents in early 2017 to 10,676 per 100,000 by the end of 2025. Bariatric surgery use peaked in 2022 and then fell about 29% through 2025, a decline lead author John Rode, M.D., M.S., said coincided with FDA approval of semaglutide for adolescents 12 and older with obesity. By late 2025, privately insured teens were prescribed GLP-1s at 2.4 times the rate of uninsured or self-pay teens.
“We found that nine out of 10 adolescents who qualified for bariatric surgery received neither treatment throughout the whole study period between 2017 and 2025,” Rode said. The findings come from health records and don't show why eligible teens went without treatment; Rode said more research is needed on how GLP-1s may change obesity care.
Here's
Florida man pleads guilty in $42M Medicare equipment and genetic testing fraud
Authorities seized a yacht valued at more than $600,000.
Chad Monroe, 48, of Tarpon Springs, Florida,
Prosecutors said Monroe and co-conspirators used three equipment companies to bill for knee, wrist, ankle and back braces and lied on Medicare enrollment documents to hide his ownership. Monroe paid purported telemedicine companies kickbacks for doctors' orders and, through his company Health and Life Networking LLC, sold genetic testing orders to laboratories that paid him more than $15 million in kickbacks. The companies submitted more than $26 million in false claims to Medicare, Medicare Advantage plans and TRICARE.
Authorities seized the yacht along with more than $1 million. Monroe faces up to 10 years in prison on the conspiracy count and up to 30 years on the wire fraud count. Sentencing has not been set.
Related to this article









